Stocks of Viking Therapeutics Inc (NASDAQ:VKTX) traded higher last session on Wall Street, down -7.45% to $49.58.
VKTX stock price is now -23.25% away from the 50-day moving average and -19.70% away from the 200-day moving average. The market capitalization of the company currently stands at $5.11B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $90 to $102, H.C. Wainwright maintained Buy rating for Viking Therapeutics Inc (NASDAQ: VKTX). On September 11, 2024, JP Morgan recently initiated its ‘Overweight’ rating on the stock quoting a target price of $80, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, MACARTNEY LAWSON, Director sold 2,000 shares of the company’s stock on Nov 08 ’24. The stock was sold for $137,333 at an average price of $68.67. Upon completion of the transaction, the Director now directly owns 47,965 shares in the company, valued at $2.38 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 08 ’24, Director LAWSON MACARTNEY bought 2,000 shares of the business’s stock. A total of $137,333 was incurred on buying the stock at an average price of $68.67. A total of 3.12% of the company’s stock is owned by insiders.
During the past 12 months, Viking Therapeutics Inc has had a low of $10.34 and a high of $99.41. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 36.47, and a quick ratio of 36.47. The fifty day moving average price for VKTX is $64.5975 and a two-hundred day moving average price translates $61.745377 for the stock.
The latest earnings results from Viking Therapeutics Inc (NASDAQ: VKTX) was released for 2024-09-30.
